Melanoma, Malignant Recruiting Phase 2 Trials for Atezolizumab (DB11595)

Also known as: Malignant Melanoma / [M]Malignant melanoma NOS / Melanoma / Melanoma malignant

IndicationStatusPhase
DBCOND0107071 (Melanoma, Malignant)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02303951Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VCTreatment